Related Experiment Video
Updated: Dec 25, 2025

06:15
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
1.3K
Lymphoproliferative disorder in a lung transplant recipient
Hassan A Haji1, Douglas S Corwin2, Jennifer Y So1
1Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
BMJ Case Reports
|April 3, 2020
Summary
Post-transplantation lymphoproliferative disorder (PTLD) is rare after organ transplants. This case highlights PTLD presenting as GI bleeding and pain in a lung transplant recipient, potentially linked to alemtuzumab induction and Epstein-Barr virus (EBV).
Area of Science:
- Immunology
- Oncology
- Transplantation Medicine
Background:
- Post-transplantation lymphoproliferative disorder (PTLD) is an uncommon but serious complication following solid organ transplantation.
- Risk factors for PTLD include Epstein-Barr virus (EBV) serologic status, with high-risk donor/recipient serologies increasing susceptibility.
- Alemtuzumab induction is used in some solid organ transplantations, but its role in PTLD development requires further investigation.
Related Concept Videos
Pulmonary Tuberculosis I
751
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
751
Tissue Transplantation
810
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
810
Kidney Transplant I: Introduction
263
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
263

